Effect of Envarsus conversion on tacrolimus-associated tremor in renal transplant patients. An open-label, single centre, prospective pharmacodynamic/pharmacokinetic clinical study Efecto del cambio a Envarsus en el temblor asociado a tacrolimus en pacientes trasplantados de riñón. Estudio clínico prospectivo farmacodinámico y farmacocinético, abierto y unicéntrico

Trial Profile

Effect of Envarsus conversion on tacrolimus-associated tremor in renal transplant patients. An open-label, single centre, prospective pharmacodynamic/pharmacokinetic clinical study Efecto del cambio a Envarsus en el temblor asociado a tacrolimus en pacientes trasplantados de riñón. Estudio clínico prospectivo farmacodinámico y farmacocinético, abierto y unicéntrico

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Aug 2017

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top